Bromodomain Protein Inhibitors Reorganize the Chromatin of Synovial Fibroblasts
Cells · 2023
DOI: 10.3390/cells12081149 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Monika Krošel und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland. Hauptthemen laut MEDLINE: Chromatin, Synoviocytes. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EMDO Foundation, Novartis Foundation for Medical-Biological Research, EULAR.
Abstract (Originalsprache)
Bromodomain- and extra-terminal domain (BET) proteins are epigenetic reader proteins that regulate transcription of their target genes by binding to acetylated histone side chains. Small molecule inhibitors, such as I-BET151, have anti-inflammatory properties in fibroblast-like synoviocytes (FLS) and in animal models of arthritis. Here, we investigated whether BET inhibition can also affect the levels of histone modifications, a novel mechanism underlying BET protein inhibition. On the one hand, FLSs were treated with I-BET151 (1 µM) for 24 h in absence and presence of TNF. On the other hand, FLSs were washed with PBS after 48 h of I-BET151 treatment, and the effects were measured 5 days after I-BET151 treatment or after an additional 24 h stimulation with TNF (5 d + 24 h). Mass spectrometry analysis indicated that I-BET151 induced profound changes in histone modifications, with a global reduction in acetylation on different histone side chains 5 days after treatment. We confirmed changes on acetylated histone side chains in independent samples by Western blotting. I-BET151 treatment reduced mean TNF-induced levels of total acetylated histone 3 (acH3), H3K18ac, and H3K27ac. In line with these changes, the TNF-induced expression of BET protein target genes was suppressed 5 d after I-BET151 treatment. Our data indicate that BET inhibitors not only prevent the reading of acetylated histones but directly influence overall chromatin organization, in particular after stimulation with TNF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland.
- Department of Rheumatology, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
- Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.
- Department of Dermatology, Allergy, and Venereology, University of Lübeck, 23562 Lübeck, Germany.
- Department of BioMedical Research, University of Bern, 3008 Bern, Switzerland.
- Department of Rheumatology and Immunology, Inselspital, Bern University Hospital, 3008 Bern, Switzerland.
ORCID-Profile: Larissa Moser, Caroline Ospelt
Förderung
- EMDO Foundation
- Novartis Foundation for Medical-Biological Research
- EULAR
Zitieren
APA
Krošel, M., Moser, L., Houtman, M., Friščić, J., Tomšič, M., Distler, O., Hoffmann, M. H., Ospelt, C., & Klein, K. (2023). Bromodomain Protein Inhibitors Reorganize the Chromatin of Synovial Fibroblasts. Cells. https://doi.org/10.3390/cells12081149
Vancouver
Krošel M, Moser L, Houtman M, Friščić J, Tomšič M, Distler O, et al. Bromodomain Protein Inhibitors Reorganize the Chromatin of Synovial Fibroblasts. Cells. 2023. doi:10.3390/cells12081149
BibTeX
@article{Kroel2023,
author = {Krošel, Monika and Moser, Larissa and Houtman, Miranda and Friščić, Jasna and Tomšič, Matija and Distler, Oliver and Hoffmann, Markus H and Ospelt, Caroline and Klein, Kerstin},
title = {Bromodomain Protein Inhibitors Reorganize the Chromatin of Synovial Fibroblasts},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12081149}
}
EUVIMED